Target intelligence / Profile preview

Extracellular protein

Molecular classification
Other
01

Overview

Extracellular proteins encompass a vast and heterogeneous group of proteins located outside the plasma membrane, including those secreted into bodily fluids and those constituting the extracellular matrix (ECM) (UniProt, 2024). They serve critical roles in maintaining tissue architecture, providing mechanical support, and facilitating intercellular communication through signaling molecules such as cytokines, growth factors, and hormones (NIH, 2023). While many specific members of this class—such as Vascular Endothelial Growth Factor (VEGF) or Tumor Necrosis Factor (TNF)—are pivotal therapeutic targets, the term 'Extracellular protein' itself is a general classification rather than a single target (Alberts et al., 'Molecular Biology of the Cell'). Dysregulation of these proteins is a hallmark of various pathologies, including cancer metastasis, where the ECM is remodeled, and chronic inflammatory diseases driven by secreted pro-inflammatory mediators (PubMed, 2022). In pharmacology, these proteins are frequently targeted by monoclonal antibodies designed to sequester ligands or block their interaction with cell-surface receptors. Because the term describes a subcellular location and functional state rather than a specific molecular entity, it does not possess a singular pharmacological profile or a unified set of interacting drugs.

Other names
Secreted proteinExtracellular matrix proteinECM proteinExoproteinCell surface associated protein
02

Mechanism of action

As a broad category, there is no single mechanism of action; specific proteins within this class are targeted by neutralizing antibodies, decoy receptors, or enzyme inhibitors.

03

Biological functions

Cell signalingStructural supportImmune responseCell adhesionHomeostasisEnzymatic activity
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseAutoimmune disease
05

Safety considerations

Systemic toxicity due to diverse physiological rolesOff-target effects when targeting common structural domainsImmunogenicity of biological therapeutics targeting secreted proteins

Beyond the preview

Go deeper on Extracellular protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call